Resected small cell lung cancer-time for more?
- PMID: 27620199
- PMCID: PMC4999769
- DOI: 10.21037/jtd.2016.07.17
Resected small cell lung cancer-time for more?
Abstract
Small cell lung cancer (SCLC) often presents with either regional or systemic metastases, but approximately 4% of patients present with a solitary pulmonary nodule. Surgical resection can be an option for these patients and is endorsed by the National Comprehensive Cancer Network (NCCN) guidelines. There are no prospective randomized clinical trials evaluating the role of adjuvant systemic therapy in these resected SCLC patients. A recent National Cancer Database analysis found that the receipt of adjuvant chemotherapy alone [hazard ratio (HR), 0.78; 95% CI, 0.63-0.95] or with brain radiation (HR, 0.52; 95% CI, 0.36-0.75) was associated with significantly improved survival as compared to surgery alone. As it is unlikely that a randomized prospective clinical trial addressing this question will be completed, these data should assist with decision making in these patients.
Keywords: Small cell lung cancer (SCLC); adjuvant chemotherapy; surgery; survival.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Comment on
-
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.J Clin Oncol. 2016 Apr 1;34(10):1057-64. doi: 10.1200/JCO.2015.63.8171. Epub 2016 Jan 19. J Clin Oncol. 2016. PMID: 26786925 Free PMC article.
References
-
- Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007;2:1067-77. 10.1097/JTO.0b013e31815bdc0d - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials